Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Dec;8(24):1700.
doi: 10.21037/atm-20-4164.

Combined locoregional and systemic therapy for advanced hepatocellular carcinoma: finally, the future is obscure

Khashayar Farsad  1 , Nima Nabavizadeh  2 , Adel Kardosh  3 , Janice H Jou  4 , Willscott E Naugler  4 , Kenneth J Kolbeck  1
Affiliations
Editorial

Combined locoregional and systemic therapy for advanced hepatocellular carcinoma: finally, the future is obscure

Khashayar Farsad et al. Ann Transl Med. 2020 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have completed the ICMJE uniform disclosure from (available at http://dx.doi.org/10.21037/atm-20-4164). KF reports other from Auxetics, Inc., personal fees from Cook Medical, personal fees from BTG, personal fees from Neuwave, grants and personal fees from Guerbet, LLC, personal fees from Genentech, personal fees from Dova Pharmaceuticals, outside the submitted work; In addition, KF has a patent “use of specific stent class for the management of venous stenosis” licensed to Auxetics, Inc. The other authors have no conflicts of interest to declare.

Comment on

References

    1. Yang JD, Hainaut P, Gores GJ, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol 2019;16:589-604. 10.1038/s41575-019-0186-y - DOI - PMC - PubMed
    1. Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet 2018;391:1301-14. 10.1016/S0140-6736(18)30010-2 - DOI - PubMed
    1. Bujold A, Massey CA, Kim JJ, et al. Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J Clin Oncol 2013;31:1631-9. 10.1200/JCO.2012.44.1659 - DOI - PubMed
    1. McPartlin AJ, Dawson LA. Stereotactic Body Radiotherapy for Hepatocellular Carcinoma. Cancer J 2016;22:296-301. 10.1097/PPO.0000000000000201 - DOI - PubMed
    1. Yoon SM, Ryoo BY, Lee SJ, et al. Efficacy and Safety of Transarterial Chemoembolization Plus External Beam Radiotherapy vs Sorafenib in Hepatocellular Carcinoma With Macroscopic Vascular Invasion: A Randomized Clinical Trial. JAMA Oncol 2018;4:661-9. 10.1001/jamaoncol.2017.5847 - DOI - PMC - PubMed

LinkOut - more resources